A detailed history of Forsta Ap Fonden transactions in Bio Techne Corp stock. As of the latest transaction made, Forsta Ap Fonden holds 36,600 shares of TECH stock, worth $2.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
36,600
Previous 33,000 10.91%
Holding current value
$2.88 Million
Previous $2.36 Million 23.69%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$70.96 - $82.35 $255,455 - $296,460
3,600 Added 10.91%
36,600 $2.92 Million
Q2 2024

Aug 08, 2024

SELL
$62.12 - $84.15 $86,968 - $117,810
-1,400 Reduced 4.07%
33,000 $2.36 Million
Q1 2024

May 07, 2024

BUY
$65.98 - $77.09 $323,302 - $377,741
4,900 Added 16.61%
34,400 $2.42 Million
Q4 2023

Feb 06, 2024

SELL
$52.83 - $78.22 $306,414 - $453,676
-5,800 Reduced 16.43%
29,500 $2.28 Million
Q3 2023

Oct 25, 2023

SELL
$67.52 - $89.42 $5.17 Million - $6.84 Million
-76,500 Reduced 68.43%
35,300 $2.4 Million
Q2 2023

Aug 03, 2023

BUY
$73.76 - $85.98 $5.52 Million - $6.44 Million
74,900 Added 202.98%
111,800 $9.13 Million
Q1 2023

Apr 21, 2023

BUY
$71.62 - $86.62 $1.99 Million - $2.41 Million
27,800 Added 305.49%
36,900 $2.74 Million
Q4 2022

Feb 02, 2023

BUY
$80.67 - $352.29 $734,097 - $3.21 Million
9,100 New
9,100 $754,000
Q2 2022

Aug 11, 2022

BUY
$322.67 - $449.65 $225,869 - $314,755
700 Added 8.97%
8,500 $2.95 Million
Q1 2022

May 09, 2022

SELL
$353.85 - $487.79 $247,695 - $341,453
-700 Reduced 8.24%
7,800 $3.38 Million
Q4 2021

Feb 11, 2022

SELL
$456.15 - $525.06 $957,915 - $1.1 Million
-2,100 Reduced 19.81%
8,500 $4.4 Million
Q2 2021

Aug 12, 2021

BUY
$387.35 - $450.26 $4.11 Million - $4.77 Million
10,600 New
10,600 $4.77 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.09B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Forsta Ap Fonden Portfolio

Follow Forsta Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.